Genpharmasec Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	626	432	1,009	1,235	861	1,523
Market Cap Growth	-46.22%	-57.18%	-18.31%	43.41%	-43.45%	-31.34%
Enterprise Value	868	491	1,021	1,221	805	1,447
Last Close Price	1.13	0.78	1.89	2.23	1.87	3.30
PE Ratio	43.20	26.94	81.93	-	76.55	-
PS Ratio	0.45	0.31	2.99	4.06	3.38	5.57
PB Ratio	0.95	0.66	1.55	1.91	5.62	9.91
P/TBV Ratio	1.30	0.90	1.55	1.92	5.62	9.91
P/OCF Ratio	-	-	33.78	-	-	-
EV/Sales Ratio	0.62	0.35	3.03	4.01	3.15	5.30
EV/EBITDA Ratio	71.03	40.15	-	5926.15	300.20	-
EV/EBIT Ratio	-	-	-	31302.23	324.00	-
Debt / Equity Ratio	0.53	0.53	0.08	0.06	0.20	-
Debt / EBITDA Ratio	28.59	28.59	82.19	84.54	11.50	-
Net Debt / Equity Ratio	0.38	0.38	-0.01	-0.28	-0.04	-0.39
Net Debt / EBITDA Ratio	20.35	20.35	2.34	-868.31	-2.14	11.40
Net Debt / FCF Ratio	-1.38	-1.38	0.35	6.04	0.19	2.45
Asset Turnover	1.28	1.28	0.45	0.67	1.23	1.11
Inventory Turnover	12.18	12.18	3.99	2.93	2.75	4.22
Quick Ratio	0.84	0.84	2.02	11.58	4.54	2.02
Current Ratio	1.71	1.71	2.78	15.16	9.17	3.43
Return on Equity (ROE)	0.86%	0.86%	1.90%	-0.42%	7.33%	-1.16%
Return on Assets (ROA)	-0.54%	-0.54%	-0.62%	0.01%	0.75%	-1.35%
Return on Invested Capital (ROIC)	-0.67%	-0.70%	-0.88%	-0.01%	1.82%	-6.79%
Return on Capital Employed (ROCE)	-1.00%	-1.00%	-1.10%	0.00%	1.40%	-3.50%
Earnings Yield	2.56%	3.71%	1.22%	-0.14%	1.31%	-0.14%
FCF Yield	-28.88%	-41.84%	-2.70%	-2.40%	-3.57%	-1.59%
Buyback Yield / Dilution	-10.69%	-10.69%	-80.25%	-10.96%	-	-2.06%